SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing heightened volatility and trader attention as the market reacts to semiconductor sector rebalancing and upcoming earnings guidance from Samsung Electronics. Community discussion is sharply divided between bulls citing the long-term AI-driven memory shortage as a catalyst for growth and bears highlighting cyclical risks and technical selling pressure.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group Corp. is trending as the community debates the platform's role in political discourse and recent volatility, specifically focusing on the intersection of the company's valuation, broader economic policy, and ongoing controversies involving political figures. Investors and detractors alike are actively discussing the stock's future, often blending market speculation with heated debates over fiscal policies and leadership decisions.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is currently trending following a transformative 20-year lease agreement with Anthropic that secures a massive multi-billion dollar revenue stream and validates its shift toward specialized AI infrastructure. While the community is debating whether this news triggered a "sell the news" event or presents a long-term accumulation opportunity, investors remain focused on the company's ability to execute on its massive data center buildout.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is experiencing heightened trading activity and bullish sentiment driven by a potential short squeeze, as investors react to limited share availability and high borrowing costs. The community is actively discussing rumors of new partnerships, leadership restructuring, and the company's autonomous vehicle strategy, while weighing these against concerns regarding long-term cash burn and dilution.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors react to the company's recent strategic hiring for data center energy storage and the ongoing validation of its solid-state battery technology through partnerships like the recent Honda research agreement. The community is actively debating the transition from long-term R&D to commercial scaling, with intense discussion around potential manufacturing catalysts and the company's positioning within the broader AI and energy infrastructure sector.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is trending due to a combination of strong Q2 delivery figures that beat expectations and a raised annual production outlook, which has energized the community despite broader market volatility. Investors are actively debating the sustainability of this momentum, specifically focusing on the strategic importance of scaling the R2 crossover and securing long-term capital to support critical infrastructure projects.

Securitize Corp. develops a tokenization platform for securities. The private company is based in FL. Carlos Domingo has been the CEO of the American company since 2017.

Securitize Corp.

Securitize is gaining attention as a pure-play leader in real-world asset tokenization following its recent public listing and innovative move to offer its own stock in both traditional and tokenized formats. Community members are actively debating the stock's long-term potential as a 'sleeping giant' while navigating volatility linked to post-merger share distribution and the transition toward on-chain finance.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending as investors weigh potential clinical trial catalysts and upcoming conference presentations against administrative filing delays. While the community remains divided over management's communication and recent accounting hurdles, sentiment is buoyed by high cost-to-borrow rates and anticipation that upcoming data readouts could trigger a significant re-rating.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

AbCellera Biologics is trending as institutional investors and the community closely monitor a series of board appointments, including a new director with significant late-stage clinical and commercialization experience, which is widely interpreted as a strategic move ahead of upcoming Phase 2 trial results. The stock is seeing heightened volume and bullish sentiment, with many observers pointing to the company's RepSeq data layer and recent partnership developments as key drivers for long-term growth as the firm pivots toward more intensive internal drug development.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

Norwegian Cruise Line Holdings Ltd is seeing heightened community discussion driven by significant insider buying activity and anticipation of a potential breakthrough in regional geopolitical tensions. Investors are closely monitoring these developments as catalysts for a sector-wide recovery, despite ongoing market volatility and skepticism regarding the cruise line's recent operational guidance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

OnKure Therapeutics (NASDAQ:OKUR) Issues Quarterly Earnings Results

OnKure Therapeutics (NASDAQ:OKUR - Get Free Report) released its quarterly earnings results on Tuesday. The company reported ($1.11) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.74) by ($0.37...

CVS Q1 Earnings Preview: Health Services Likely to Lead Performance

CVS Health heads into Q1 earnings results with Health Services growth expected to offset pressure in benefits, as revenues dip slightly and costs remain elevated.

OnKure Therapeutics (OKUR) Projected to Post Quarterly Earnings on Tuesday

OnKure Therapeutics (NASDAQ:OKUR) will be releasing its Q1 2026 earnings before the market opens on Tuesday, May 5. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-5-onkure-therapeutics-stock...

Short Interest in OnKure Therapeutics, Inc. (NASDAQ:OKUR) Drops By 57.6%

OnKure Therapeutics, Inc. (NASDAQ:OKUR - Get Free Report) was the target of a large decrease in short interest in the month of April. As of April 15th, there was short interest totaling 69,494 shares, a decrease of 57.6% from the March 31st total of 163,904 shares. Currently, 0.5% of the shares of...

TMO Q1 Earnings Preview: Will Life Sciences Solutions Lead Results?

Thermo Fisher heads into Q1 earnings with Life Sciences Solutions growth in focus, as bioproduction strength and new innovations may drive results.

Short Interest in OnKure Therapeutics, Inc. (NASDAQ:OKUR) Increases By 1,958.6%

OnKure Therapeutics, Inc. (NASDAQ:OKUR - Get Free Report) saw a large increase in short interest in March. As of March 31st, there was short interest totaling 163,904 shares, an increase of 1,958.6% from the March 15th total of 7,962 shares. Based on an average daily volume of 786,389 shares, the...

OnKure Therapeutics, Inc. (NASDAQ:OKUR) Short Interest Down 85.2% in March

OnKure Therapeutics, Inc. (NASDAQ:OKUR - Get Free Report) was the target of a significant decline in short interest in March. As of March 13th, there was short interest totaling 7,962 shares, a...

HC Wainwright Has Positive Forecast for OKUR Q1 Earnings

OnKure Therapeutics, Inc. (NASDAQ:OKUR - Free Report) - Stock analysts at HC Wainwright upped their Q1 2026 earnings per share (EPS) estimates for OnKure Therapeutics in a research note issued to...

OnKure Therapeutics (NASDAQ:OKUR) Price Target Lowered to $27.00 at HC Wainwright

HC Wainwright dropped their price objective on OnKure Therapeutics from $34.00 to $27.00 and set a "buy" rating on the stock in a research report on Monday...

OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer. It is headquartered in Boulder, CO.

OnKure Therapeutics Inc. - Ordinary Shares - Class A

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

OKUROnkure Therapeutics Inc

Fundamentals

Latest OKUR News